Lee Michelle D, Kennett Guy A, Dourish Colin T, Clifton Peter G
Laboratory of Experimental Psychology, University of Sussex, Brighton, East Sussex, BN1 9QG, UK.
Psychopharmacology (Berl). 2002 Oct;164(1):49-60. doi: 10.1007/s00213-002-1162-7. Epub 2002 Jul 19.
5-HT(1B) receptors are thought to be one of the receptor subtypes that mediate the inhibitory control of serotonin on food intake and satiety.
To use the selective 5-HT(1B) receptor agonist, CP-94,253 as a probe of 5-HT(1B) receptor function in feeding behaviour, and to confirm the pharmacological selectivity of CP-94,253-induced hypophagia with a range of antagonists.
Dose-response functions for CP-94,253 (0, 1.25, 2.5, 5.0 mg/kg; IP) were determined in animals consuming wet mash in a 40-min test session during which time-sampled behavioural observations were collected to evaluate satiety sequences. A meal patterning study was carried out in a separate group of rats. The 5-HT(1A) antagonist WAY 100,635 (0, 1.0, 3.0 mg/kg; SC), the 5-HT(1B/1D)antagonist GR 127,935 (0, 3 mg/kg; IP), and the 5-HT(1B) antagonist SB 224289 (0, 2.5, 5.0 mg/kg; IP) were used to confirm that 5-HT(1B) receptor subtypes were responsible for the action of CP-94,253 on feeding behaviour.
CP-94,253 (2.5 mg/kg) reduced food intake and preserved the satiety sequence in animals consuming a diet of mash. GR 127,935 (3.0 mg/kg) and SB 224289 (2.5 mg/kg), but not WAY 100,635, attenuated the hypophagic effect of the 5-HT(1B) agonist, and returned the changes in satiety sequence to control patterns. Meal patterning analyses indicated that CP-94,253 (2.5 mg/kg) reduced food intake through a decrease in meal size and duration in the absence of any alteration in the rate of eating. A hypodipsic action of CP-94,253 was also observed (2.5 and 5.0 mg/kg).
These findings imply that 5-HT(1B) receptors regulate discrete elements of satiety. We discuss the potential role of 5-HT(1B) agonists for the treatment of obesity.
5-羟色胺(5-HT)(1B)受体被认为是介导5-羟色胺对食物摄入和饱腹感进行抑制性控制的受体亚型之一。
使用选择性5-HT(1B)受体激动剂CP-94,253作为研究5-HT(1B)受体在摄食行为中功能的探针,并使用一系列拮抗剂来证实CP-94,253诱导的摄食减少的药理学选择性。
在40分钟的测试时段内,给食用湿软食的动物腹腔注射CP-94,253(0、1.25、2.5、5.0毫克/千克),测定其剂量反应函数,在此期间收集定时采样的行为观察数据以评估饱腹感序列。在另一组大鼠中进行了进餐模式研究。使用5-HT(1A)拮抗剂WAY 100,635(0、1.0、3.0毫克/千克;皮下注射)、5-HT(1B/1D)拮抗剂GR 127,935(0、3毫克/千克;腹腔注射)和5-HT(1B)拮抗剂SB 224289(0、2.5、5.0毫克/千克;腹腔注射)来证实5-HT(1B)受体亚型是CP-94,253对摄食行为起作用的原因。
CP-94,253(2.5毫克/千克)减少了食用软食动物的食物摄入量,并保留了饱腹感序列。GR 127,935(3.0毫克/千克)和SB 224289(2.5毫克/千克),而非WAY 100,635,减弱了5-HT(1B)激动剂的摄食减少作用,并使饱腹感序列的变化恢复到对照模式。进餐模式分析表明,CP-94,253(2.5毫克/千克)在不改变进食速率的情况下,通过减小餐量和缩短进餐持续时间来减少食物摄入量。还观察到CP-94,253(2.5和5.0毫克/千克)有降低饮水的作用。
这些发现表明5-HT(1B)受体调节饱腹感的不同要素。我们讨论了5-HT(1B)激动剂在治疗肥胖症方面的潜在作用。